Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest U.S. Securities and Exchange Commission Stories

2014-04-14 12:33:56

WOODLAND HILLS, Calif., April 14, 2014 /PRNewswire/ -- GrowLife, Inc. (OTCBB: PHOT), a diversified company operating in the legal cannabis industry which develops, markets and deploys products and services of legal cannabis, has released an open letter to shareholders: Dear Shareholders: The SEC determined on April 10, 2014 to impose a temporary trading halt in GrowLife stock that may extend through April 24, 2014. This communication is to inform shareholders of the information...

2014-04-10 16:24:08

WOODLAND HILLS, Calif., April 10, 2014 /PRNewswire/ -- GrowLife, Inc. (OTCBB: PHOT), a diversified company operating in the legal cannabis industry which develops, markets and deploys products and services of legal cannabis, learned this morning that the SEC temporarily halted trading of GrowLife's stock. We were not notified in advance, but have contacted the SEC to better understand the basis of the complaint. We will fully comply with the SEC's requests for information, and...

2014-04-10 12:30:07

XIAMEN, FUJIAN, China, April 10, 2014 /PRNewswire/ -- China Xiniya Fashion Limited ("Xiniya" or the "Company") (NYSE: XNY) announces that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2013 with the United States Securities and Exchange Commission (the "SEC"), which includes its audited financial statements. Pursuant to Section 203.01 of the New York Stock Exchange ("NYSE") Listed Company Manual, the requirement for an NYSE-listed company to...

2014-04-10 12:27:35

TORONTO, April 10, 2014 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has closed its previously announced public offering (the "Offering"). Pursuant to the Offering, SQI issued 8,400,000 units of the Company ("Units") at a price of C$0.50 per Unit for gross proceeds of C$4.2 million....

2014-04-10 08:30:21

Funding Will Accelerate Expansion of European Manufacturing BETHESDA, Md., April 10, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that on April 9, 2014, it entered into an agreement with a single institutional investor for a registered direct placement of up to $32 million. The Stock Purchase Agreement provides for the sale of an initial $15...

2014-04-10 08:22:09

PEORIA, Ill., April 10, 2014 /PRNewswire/ -- Caterpillar Inc. (NYSE: CAT) will release 2014 first-quarter financial results at 6:30 a.m. Central Time on Thursday, April 24, 2014. The release will be available at caterpillar.com/earnings and the full text of the news release will also be available on PR Newswire at about 6:30 a.m. Central Time. The news release will be furnished to the U.S. Securities and Exchange Commission (SEC) via a Current Report on Form 8-K in compliance with...

2014-04-10 08:21:33

VAN BUREN, Ark., April 10, 2014 /PRNewswire/ -- USA Truck, Inc. (NASDAQ: USAK), a leading North American transportation and logistics solutions provider, today announced that its Board of Directors has unanimously voted to terminate the Company's Stockholders' Rights Plan (the "Plan") effective April 11, 2014. http://photos.prnewswire.com/prnvar/20110114/DA30069LOGO Chairman of the Board Robert A. Peiser commented, "We adopted the Stockholders' Rights Plan in November 2012 as we...

2014-04-08 16:23:30

CASTLE ROCK, Colo., April 8, 2014 /PRNewswire/ -- Venaxis, Inc. (NASDAQ:APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1(TM) Test, a rapid, multiple biomarker-based index assay for identifying patients that are at low risk for appendicitis, today announced the closing of its previously announced underwritten public offering of 8,335,000 shares of its common stock at a price to the public of $2.40 per share. In...

2014-04-08 12:31:23

Company invites Main Street and Wall Street investors to attend interactive real-time virtual conference NEW YORK, April 8, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) the San Diego-based regenerative medicine company focused on using its breakthrough NovoGen 3D human tissue printing technology to create tissue on demand for medical research and therapeutic applications, today announced that Keith Murphy, CEO, will present at RetailInvestorConferences.com. DATE: April 10,...

2014-04-08 08:37:12

Glenn Daniel, former Managing Partner at Houlihan Lokey; Harry Kellogg, former Vice Chairman of Silicon Valley Bank; Michael Southworth, Chief Financial Officer at Contact Solutions LLC NEW YORK, April 8, 2014 /PRNewswire/ -- Finjan Holdings, Inc. (OTC MKT: FNJN) (the "Company") today announced the appointments of three new members to its Board of Directors. They are Glenn Daniel, former Managing Partner at the global investment bank Houlihan Lokey; Harry Kellogg, former Vice...